Document is current
Any future updates will be listed below
-
Authors
Rossanti, Rini
Nozu, Kandai
Fukunaga, Atsushi
Nagano, China
Horinouchi, Tomoko
Yamamura, Tomohiko
Sakakibara, Nana
Minamikawa, Shogo
Ishiko, Shinya
Aoto, Yuya
Okada, Eri
Ninchoji, Takeshi
Kato, Noritoshi
Maruyama, Shoichi
Kono, Keiji
Nishi, Shinichi
Iijima, Kazumoto
Fujii, Hideki
-
Funding
Funding for this research was provided by:
Ministry of Education, Culture, Sports, Science and Technology (19K08726)
- License Information
-
More Information
Article History
Received: 6 December 2020
Accepted: 9 June 2021
First Online: 14 June 2021
Declarations
:
: Kandai Nozu has received lecture fees from Sumitomo Dainippon Pharma. Atsushi Fukunaga has received lecture fees from Sumitomo Dainippon Pharma and Sanofi K.K. Kazumoto Iijima has received lecture fees from Sanofi K.K. Hideki Fujii has received lecture fees from Sumitomo Dainippon Pharma, Sanofi K.K., and Amicus Therapeutics.
: All procedures performed in this study were reviewed and approved by the Institutional Review Board of Kobe University Graduate School of Medicine (IRB approval number 019-301) and performed in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Written informed consent for conducting this study was obtained from all participants.
